Page 239 - Multidisipliner Covid 19

‹mmün (Konvelesan) Plazma Tedavisi

with COVID-19 with Convalescent Plasma. JAMA - J Am Med Assoc.
2020;323(16):1582-1589. doi:10.1001/jama.2020.4783
17. Tanne JH. Covid-19: FDA approves use of convalescent plasma to treat
critically ill patients. BMJ. 2020;368(March):m1256. doi:10.1136/bmj.m
1256
18. US FDA. Investigational COVID-19 Convalescent Plasma - Emergency
INDs. Https://WwwFdaGov/Vaccines-Blood-Biologics/Investigational-New-
Drug-Ind-or-Device-Exemption-Ide-Process-Cber/Investigational-Covid-19-
Convalescent-Plasma-Emergency-Inds. Published online 2020:1-3.https://
www.fda.gov/vaccines-blood-biologics/investigational-new-drug-
ind-or-device-exemption-ide-process-cber/investigational-covid-19-
convalescent-plasma-emergency-inds
19. Sağlık Bakanlığı. Covid-19 immün (konvalesan) plazma tedarik ve
klinik kullanim rehberi. Published online 2020.
20. Li L, Zhang W, Hu Y, et al. Effect of Convalescent Plasma Therapy on
Time to Clinical Improvement in Patients With Severe and Life-
threatening COVID-19. Jama. Published online 2020.doi:10.1001/jama.
2020.10044
21. Rajendran K, Narayanasamy K, Rangarajan J, Rathinam J, Natarajan
M, Ramachandran A. Convalescent plasma transfusion for the treatment
of COVID-19: Systematic review. J Med Virol. 2020;(April):1-9.doi:10.
1002/jmv.25961
22. Valk SJ, Piechotta V, Chai KL, et al. Convalescent plasma or hyperim-
mune immunoglobulin for people with COVID-19: a rapid review.
Cochrane Database Syst Rev. 2020;2020(5).doi:10.1002/14651858. CD013600
23. Barone P, DeSimone RA. Convalescent plasma to treat coronavirus
disease 2019 (COVID-19): considerations for clinical trial design. Trans-
fusion. 2020;2019. doi:10.1111/trf.15843
24. Gasparyan AY, Misra DP, Yessirkepov M, Zimba O. Perspectives of
immune therapy in coronavirus disease 2019. J Korean Med Sci.2020;35
(18):1-9. doi:10.3346/JKMS.2020.35.E176
25. Jawhara S. Could intravenous immunoglobulin collected from recovered
coronavirus patients protect against covid-19 and strengthen the im-
mune system of new patients? Int J Mol Sci. 2020;21(7).doi:10.3390/
ijms21072272

238